Zhonghong Medical: Its subsidiary, retentive needle products, are expected to be selected for the "3+N" alliance joint procurement in Beijing-Tianjin-Hebei region.

Zhonghong Medical announced that its holding subsidiary Kelen Medical Device plans to be selected for the "3+N" Alliance of Beijing-Tianjin-Hebei for the reserved needle category of medical consumables volume-linked procurement project, with a planned selected price of 3.09 yuan per support. Kelen Medical Device's reserved needle products had sales revenue of 3.9422 million yuan in 2024, accounting for 0.16% of the company's revenue for that year. If purchase and sales contracts are signed and implemented in the future, it will expand the market sales of products. However, the relevant procurement contracts have not been signed yet, and the extent of their impact is uncertain.